Chronic tendon injuries — often stubbornly slow to heal through conservative treatment alone — are an active area of regenerative medicine research, with both stem cell and exosome approaches under investigation.
As of 2026, neither the FDA nor INVIMA (Colombia's regulatory authority) has approved stem cell, PRP, or exosome products specifically for most orthopedic or aesthetic indications. This does not mean these treatments are unsafe or ineffective — it means they operate in a space where clinical evidence and regulatory approval haven't yet aligned. Any provider should be transparent about this distinction.
Why tendons are a specific research focus
Tendon tissue has notoriously limited natural blood supply, which is part of why chronic tendon injuries heal so slowly through the body's own processes. This is exactly the kind of biological challenge regenerative approaches aim to address — supporting healing signals in tissue that doesn't easily generate them on its own.
Tendon-derived stem cells and exosome approaches show encouraging results in preclinical and early clinical research specifically for tendon repair — but this remains an evolving evidence base rather than a fully established standard of care, worth understanding honestly before pursuing.
Common conditions patients research this for
- Chronic Achilles tendinopathy
- Rotator cuff tendon injuries not requiring or responding to surgical repair
- Patellar tendinopathy
- Chronic tennis or golfer's elbow (lateral/medial epicondylitis)
How this compares to standard conservative treatment
Physical therapy, activity modification, and time remain the first-line, most evidence-supported approach for most tendon injuries. Regenerative treatment is generally considered for cases that haven't responded adequately to conservative management, not as a first-line replacement for it.
What to ask before pursuing this
Ask specifically what evidence supports this treatment for your particular tendon and injury type — the evidence base varies meaningfully by specific tendon and condition, and a responsible provider should be able to discuss this specificity rather than a blanket claim.
Ready to talk to someone?
Message us on WhatsApp for a free, no-obligation consultation.